GlassScriptPhysician profile
Michael G Welch
NPI 1912934183
$13,444.54
in general payments reported to CMS, 2019-2025
43 companies · $4,284 in 2025
The $4,284 reported for 2025 was more than what 95% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,660 · 2020: $273 · 2021: $1,713 · 2022: $1,155 · 2023: $1,097 · 2024: $1,263 · 2025: $4,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,557 · Travel and Lodging: $2,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,556.53 |
| Travel and Lodging | $2,087.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,136.84 | 2019-2025 | Pico, Collagenase Santyl, Grafix |
| Stryker Corporation | $3,489.35 | 2019-2025 | Prostep Mica, Citrefix, Dart-Fire |
| Treace Medical Concepts, INC. | $1,025.34 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $792.48 | 2019-2022 | |
| Kerecis Limited | $577.59 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $454.20 | 2020-2025 | Nuzyra |
| Abbvie INC. | $253.62 | 2022-2024 | Dalvance, Avycaz, Teflaro |
| Misonix INC | $226.22 | 2019-2021 | |
| Kci USA, INC. | $207.68 | 2019 | |
| Paragon 28, INC. | $206.03 | 2021-2024 | Portfolio |
| Depuy Synthes Sales INC. | $197.40 | 2022-2025 | Motoband, Biocryl, Healix Knotless Peek |
| Amgen INC. | $170.43 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $157.66 | 2019-2022 | |
| Horizon Therapeutics Plc | $143.49 | 2023 | Krystexxa |
| Next Science LLC | $138.07 | 2022-2023 | Surgx, Blastx, Xperience |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $135.22 | 2023 | Dynanail Helix, Washer, 15 Mm, Dynanail Hybrid, Dynanail |
| Averitas Pharma INC. | $124.99 | 2025 | Qutenza |
| Melinta Therapeutics, LLC | $83.89 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $63.21 | 2021-2025 | Jublia |
| Reprise Biomedical, INC. | $62.93 | 2024-2025 | Miro3d |
| Hydrofera LLC | $62.70 | 2021-2022 | |
| Acera Surgical, INC. | $52.40 | 2021-2025 | Restrata Wound Matrix |
| Nevro Corp. | $51.82 | 2022 | |
| Bioventus LLC | $49.21 | 2022-2023 | |
| Wright Medical Technology, INC. | $48.23 | 2019 | |
| Globus Medical, INC. | $42.67 | 2023 | Ankle Fracture System |
| Solventum Corporation | $42.61 | 2024-2025 | Activ.A.C., Promogran Prisma |
| Relja Innovations INC | $40.29 | 2023 | |
| Urgo Medical North America, LLC | $40.02 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Aroa Biosurgery Incorporated | $35.55 | 2022 | |
| Checkpoint Surgical, INC | $34.56 | 2020-2021 | |
| Convatec INC. | $34.53 | 2025 | |
| Reapplix INC. | $32.26 | 2024 | 3c Patch Kit - Box |
| Grt US Holding, INC. | $31.77 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.45 | 2023 | Seglentis |
| Orthofix Medical, INC. | $28.63 | 2024 | Physio-Stim |
| Biotissue Holdings INC. | $28.27 | 2021 | |
| Heron Therapeutics, INC. | $26.34 | 2021-2022 | |
| Eclipse Technology Solutions INC. | $20.91 | 2024 | |
| Osiris Therapeutics INC. | $20.00 | 2019 | |
| Integra Lifesciences Corporation | $17.60 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $16.88 | 2025 | |
| Advanced Oxygen Therapy INC. | $11.20 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.